Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Total Current Liabilities (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Total Current Liabilities for 16 consecutive years, with $261353.0 as the latest value for Q3 2025.

  • On a quarterly basis, Total Current Liabilities fell 21.02% to $261353.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $261353.0, a 21.02% decrease, with the full-year FY2024 number at $327644.0, down 11.78% from a year prior.
  • Total Current Liabilities was $261353.0 for Q3 2025 at Creative Medical Technology Holdings, down from $277644.0 in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $3.5 million in Q3 2021 to a low of $261353.0 in Q3 2025.
  • A 5-year average of $928678.5 and a median of $390959.0 in 2024 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: crashed 97.41% in 2021, then soared 216.21% in 2022.
  • Creative Medical Technology Holdings' Total Current Liabilities stood at $1.1 million in 2021, then skyrocketed by 216.21% to $3.3 million in 2022, then plummeted by 88.82% to $371394.0 in 2023, then dropped by 11.78% to $327644.0 in 2024, then decreased by 20.23% to $261353.0 in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Total Current Liabilities are $261353.0 (Q3 2025), $277644.0 (Q2 2025), and $286387.0 (Q1 2025).